AstraZeneca inks $6.9-bn breast, gastric cancer therapy deal with Daiichi

AstraZeneca said the transaction won't impact earnings this year but will make a 'significant contribution' by 2023

from Latest News https://ift.tt/2HLWMPa
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share